Sell Cadila Healthcare, target Rs 345: Dr CK Narayan
Sell Cadila Healthcare Ltd. at a price target of Rs 345.0 and a stoploss at Rs 362 from entry point.

Cadila Healthcare Ltd., incorporated in 1995, is a largecap company with a market cap of Rs 36296.79 crore. Cadila Healthcare Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 3098.00 Crore to Sales Value (94.60 % of Total Sales), Export Incentives which contributed Rs 85.00 Crore to Sales Value (2.59 % of Total Sales), Other Operating Revenue which contributed Rs 82.10 Crore to Sales Value (2.50 % of Total Sales) and Royalty Income which contributed Rs 9.40 Crore to Sales Value (0.28 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 2768.70 Crore, down -12.18 % from last quarter Sales of Rs 3152.70 Crore and up 29.64 % from last year same quarter Sales of Rs 2135.70 Crore Company has reported net profit after tax of Rs 449.20 Crore in latest quarter. The company’s top management includes Dr.Sharvil P Patel, Mr.Apurva S Diwanji, Mr.Ganesh N Nayak, Mr.Humayun R Dhanrajgir, Mr.Mukesh M Patel, Mr.Nitin R Desai, Mr.Pankaj R Patel, Ms.Dharmishta N Rawal. Company has Mukesh M Shah & Co. as its auditoRs As on 30-06-2018, the company has a total of 1,023,742,600 shares outstanding.
Download ET Markets APP